Control of variceal bleeding in a patient with severe haemophilia A and factor VIII inhibitors using a transjugular intrahepatic portosystemic shunt
E. HURST,
E. HURST
Haematology, Royal Victoria Infirmary, Newcastle Upon Tyne, UK
Search for more papers by this author K. TALKS,
K. TALKS
Haematology, Royal Victoria Infirmary, Newcastle Upon Tyne, UK
Search for more papers by this author J. HANLEY,
J. HANLEY
Haematology, Royal Victoria Infirmary, Newcastle Upon Tyne, UK
Search for more papers by this author
E. HURST,
E. HURST
Haematology, Royal Victoria Infirmary, Newcastle Upon Tyne, UK
Search for more papers by this author K. TALKS,
K. TALKS
Haematology, Royal Victoria Infirmary, Newcastle Upon Tyne, UK
Search for more papers by this author J. HANLEY,
J. HANLEY
Haematology, Royal Victoria Infirmary, Newcastle Upon Tyne, UK
Search for more papers by this author
First published: 21 June 2010
Dr Erin Hurst, MBBS, Haematology, Royal Victoria Infirmary, Queen Victoria Road, Newcastle Upon Tyne NE1 4LP, UK.Tel.: +44 0191 233 6161; fax: +44 0191 282 0814;e-mail:
[email protected] No abstract is available for this article.
References
- 1
Jalan R,
Hayes PC.
UK guidelines on the management of variceal haemorrhage in cirrhotic patients.
Br Soc Gastroenterol
2000; 46 (suppl 3): 1–15.
- 2
Beirne JP,
Bloom AI,
Bass NM
et al.
Safety and efficacy of TIPS in patients with haemophilia and cirrhosis.
J Vasc Interv Radiol
2007; 18: 309–12.
- 3
Hay C,
Brown S,
Collins D,
Keeling D,
Liesner R.
The diagnosis and management of Factor VII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.
Br J Haematol
2006; 133: 591–605.
- 4
Mehta R,
Parameswaran R,
Shapiro AD.
An overview of the history, clinical practice concerns, comparative studies and strategies to optimize therapy of bypassing agents.
Haemophilia
2006; 12(Suppl. 6): 54–61.
- 5
Schneiderman J,
Nugent DJ,
Young G.
Sequential therapy with activated prothrombin complex concentrate and recombinant factor VIIa in patients with severe haemophilia and inhibitors.
Haemophilia
2004; 10: 347–51.
